Back
Invesco S&P 500® High Beta ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
64
SPHB
Invesco S&P 500® High Beta ETF
Last Price:
84.03
Seasonality Move:
2.5%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
64
Invesco S&P 500® High Beta ETF (SPHB)
is a Buy
Is Invesco S&P 500® High Beta ETF a Buy, Sell or Hold?
- The current Invesco S&P 500® High Beta ETF [SPHB] share price is $84.01. The Score for SPHB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SPHB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPHB Stock Price Chart
What is Invesco S&P 500® High Beta ETF's stock price today?
-
The Invesco S&P 500® High Beta ETF share price today is $84.01
The current trend is moderately bearish and SPHB is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
SPHB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 49.98 | Sell |
Chaikin Money Flow: | 111795 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.24 - 84.86) | Sell |
Bollinger Bands (100): | (82.24 - 85.46) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | 84619 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Sell |
Bollinger Bands (100): | (40.86 - 48.8) | Sell |
SPHB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 84.39 | Sell |
20-day SMA: | 83.87 | Buy |
50-day SMA: | 83.36 | Buy |
200-day SMA: | 78.8 | Buy |
8-day EMA: | 84.2 | Sell |
20-day EMA: | 84.08 | Sell |
50-day EMA: | 83.82 | Buy |
200-day EMA: | 80.16 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.53 | Buy |
20-day SMA: | 40.36 | Sell |
50-day SMA: | 41.57 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.71 | Buy |
20-day EMA: | 40.38 | Sell |
50-day EMA: | 41.84 | Sell |
200-day EMA: | 43.38 | Sell |
Invesco S&P 500® High Beta ETF Earnings Growth & SPHB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Invesco S&P 500® High Beta ETF Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |